ALLOGENEIC erythrocyte transfusions are associated with increased mortality, 1 major
adverse cardiac and noncardiac outcome, 2 and low output failure in cardiac surgery …

BLOOD management has been defined as “the appro-priate use of blood and blood
components, with a goal of minimizing their use.”‡ This goal has been motivated historically …

Background In cancer patients, allogeneic blood transfusion is associated with poorer
prognosis, but the independent effect of the transfusion is controversial. Moreover, mediating …

There remains controversy as to when patients undergoing cardiac surgery should receive a
transfusion and whether a low hematocrit and its treatment with a transfusion of red cells …

Transfusion of allogeneic blood products during and after cardiac operations is common.
When the degree of anemia and the consequent decrease in oxygen delivery lead to organ …

Patient blood management1, 2 incorporates patient-centered, evidence-based medical and
surgical approaches to improve patient outcomes by relying on the patient's own …

Background: Several studies have indicated that a restrictive erythrocyte transfusion strategy
is as safe as a liberal one in critically ill patients, but there is no clear evidence to support the …

Preoperative anaemia is frequent in surgical patients and increases postoperative mortality,
major morbidity, and length of hospital stay. 1 Poorly controlled bleeding and surgical blood …

The prevalence of anemia is high in patients undergoing cardiac surgery. There is enough
evidence that the presence of anemia increases perioperative mortality and morbidity both …

Background The impact of intraoperative erythrocyte transfusion on outcomes of anemic
patients undergoing noncardiac surgery has not been well characterized. The objective of …